← Eichor
Study identifier: NCT06179329 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG

Condition: Cardiac Disease · Surgery-Complications · Graft Failure  ·  Sponsor: University of Sao Paulo General Hospital

PhaseNA
Planned participants150
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

The use of a graft from the left internal thoracic artery to the left anterior descending artery has become the gold standard for the indication of coronary artery bypass grafting. However, choosing a graft for the second-best coronary artery, focusing on long-term patency, is still a challenge. The saphenous vein using the "no-touch" technique is an alternative to a radial artery graft, but there is little evidence, especially in women. This randomized clinical study aims to compare the patency of these grafts in the second-best coronary artery in women undergoing coronary artery bypass grafting.

This description comes directly from the study's public registry record.

Talk to the study team

Omar A V Mejia, MD, PhD  ·  +551126615014  ·  omarvmejia@incor.usp.br

Leonardo L Lacava, MD  ·  +55 49 33224453  ·  lacavalopes@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São PauloSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06179329